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ABSTRACT
We report the concise synthesis of several tricyclic 2-pyridones via a one pot
sequence involving an aldol condensation, alkene isomerization, intramolecular DielsAlder cycloaddition, and selective retro-Diels-Alder cycloreversion. The starting
materials are synthesized in one step from cheap and commercially available
precursors. The intermediate [2.2.2]diazabicycloalkene cycloadducts can be isolated.
The retro-Diels-Alder occurs at easily accessible temperatures due to base
acceleration. Simple derivatization of the tricyclic products afforded azafluorenones
with unprecedented fluorescent activity due to the pyridone motif.
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Chapter 1
2-Pyridones: Background and Prior Syntheses
Background
Nitrogen containing heterocycles are some of the most ubiquitous structural
motifs in natural products and leading pharmaceutical drugs.1 Of the nearly two
thousand unique FDA approved small molecule pharmaceuticals, 84% contain
nitrogen, while 59% contain at least one nitrogen heterocycle. Pyridine is an aromatic
six-membered ring equivalent to benzene with a nitrogen replacing a methine group.
It is one of the most common N-heterocyclic motifs found in pharmaceuticals, second
in prevalence only to its saturated piperidine counterpart. Pyridines comprise
essential human nutrients such as niacin (vitamin B3), nicotinamide, and pyridoxine
(vitamin B6).2 Nicotinamides are precursors to the coenzymes nicotinamide adenine
dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NAPH), which
act as electron carriers for cellular respiration (Figure 1.1).3

Figure 1.1 Naturally occurring pyridine compounds
Pyridines in a higher oxidation state, as an aromatic amide, are referred to as
pyridones. 2- or 4-Pyridones exist, named for the relative placement of the carbonyl
1

to the nitrogen in the ring (Figure 1.2). This thesis is focused on 2-pyridones only, as
4-pyridones encompass differing classes of natural products which have their own
synthetic challenges. From here on, references to “pyridones” will refer only to 2pyridones.

Figure 1.2 Structure of 2- and 4-pyridones
2-Pyridones are naturally occurring compounds with unique and varied
structural and aggregate properties, and promising bioactivities. 2-Pyridones are
secondary metabolites formed by a wide variety of species. Synthesis of the 2pyridone structural motif has a long history in synthetic organic chemistry and many
complex natural product total syntheses of pyridone-containing alkaloids have been
completed.4
Properties of 2-Pyridones
2-Pyridones exists in two tautomeric forms, as an equilibrium between 2pyridone and 2-hydroxypyridine.5 2-Pyridones form hydrogen bonded dimers with the
N and O atoms of both tautomers (Figure 1.3),6 as well as stable crystalline complexes
with amino acids.7 This unique functionality has been used to make molecular
aggregates of dipyridones8 as well as self-assembling, surface-rolling molecular
machines called nanocars.9 Pyridone hydrogen bonding strength increases in
presence of strong hydrogen bonding solvents, such as hexafluoroisopropanol
(HFIP).10 Intrinsic tautomer preference has been a subject of debate, as there is less
2

than a 2 kcal difference between the hydroxypyridine and pyridone tautomers, which
differs by computational method and by state.11

Figure 1.3 Tautomerization and dimerization of pyridones
N-Substituted pyridones have differing properties and varying utility. N-Fluoro
pyridones have been used as mild fluorinating agents. 12 N-Etherealpyridones, the
alkylated derivatives of N-hydroxypyridones present in many natural products, form
carbon and oxygen centered radicals upon exposure to UV light, potentially causing
photooxidative

damage

to

DNA.13,

14

Pyridones

have

been

fused

to

borondipyrromethene (BODIPY) dyes, red-shifting their fluorescent emissions, for use
as unsymmetrical fluorescent probes (Figure 1.4).15

Figure 1.4 Niche applications of pyridones
2-Pyridone Natural Products and Total Synthesis
There are far too many pyridone natural products to detail individually. Instead,
the natural products with the most historical synthetic effort will be discussed first.
Then, selected compounds representative of natural product families will be
3

presented to highlight both the overall structural variety found in 2-pyridone natural
products and the naturally occurring substitutions to the 2-pyridone core.
Camptothecin was first isolated in 1966 from Camptotheca acuminate, a plant
used in Chinese Traditional Medicine.16 The compound showed high anticancer
activity, leading to initial total syntheses in the 1960s and 1970s. 17 Interest waned
when it failed clinical trials. In the 1980s, it was discovered that camptothecin
modulated DNA topoisomerase I, renewing interest in the compound as a selective
anti-cancer agent. After two international meetings dedicated solely to camptothecin,
the analogues topotecan and irinotecan were developed and subsequently approved
by the FDA. Topotecan is used in the treatment of ovarian cancer and lung cancer,
while irinotecan is used for colon cancer and small cell lung cancer (Figure 1.5). 17

Figure 1.5 Camptothecin and derived therapeutics
There are over a hundred completed total syntheses of camptothecin and
analogues, but special recognition should go to the work accomplished by
Danishefsky,18, 19 Boger,20 and Lu.21 Danishefsky accomplished a concise synthesis
of the racemate in 1993. Boger synthesized the (+) enantiomer in 2002. Finally, in
2012, Lu completed a synthesis of enantiopure camptothecin in 11 steps and 14%
overall yield, in a scalable synthesis requiring no chromatography. The synthetic
efforts over the past fifty years have led to camptothecin being commercially available
4

from chemical suppliers in gram quantities.
Huperzine A and B were first isolated in 1985 from the firmoss Huperzia serrata
(Figure 1.6).22 The huperzine alkaloids belong to the Lycopodium family of related
clubmoss derived natural products. Huperzine A displays antibacterial and
insecticidal properties, but its acetylcholinesterase inhibition drew interest in the
compound as a medication against Alzheimer’s disease. 23 However, clinical trials to
treat Alzheimer’s with huperzine A did not succeed, with some studies showing little
cognitive benefit.24 A meta-analysis of random clinical trials suggested the drug was
beneficial but that many of the trials had poor methodological quality, 25 a likely reason
as to why western medicine adopted alternative acetylcholinesterase inhibitors. Still,
a recent study showed that a low concentration of huperzine A increased the
proliferation of neural stem cells in adult mice,26 opening the drug to newer treatments
involving directed stem cells.27

Figure 1.6 Structure of huperzine A and B
First synthesized in 1989 by Kozikowski,28 enantiopure syntheses followed
shortly after.29 Huperzine A, while readily available from natural sources and sold in
herbal remedies,30 has been synthesized extensively30-34 due to the challenge of
efficiently constructing its multiply fused-rings. The Herzon group accomplished the
synthesis in the fewest formal steps (8, typical syntheses are 10-20), highest yield
(35-45%) and on a multigram scale.33 Tudhope and coworkers adapted the prior
5

syntheses to process chemistry, furnishing 275 grams in a single, cGMP-compliant
pass which is scalable to kilograms and bypasses chromatography. 34 A common
characteristic of these syntheses is using 2-methoxypyridine as a synthon for 2pyridone, to be revealed at the end (Scheme 1.1). This has the advantage of avoiding
pyridone reactivity (and chromatographic polarity) throughout the synthesis and
preventing the potent and highly skin permeable bioactivity of huperzine A until the
end.33

Scheme 1.1 Pyridone nucleus revealed at the end of Huperzine A synthesis, with
concomitant decarboxylation
While Huperzine A and many derivatives35-37 have been synthesized, there has
been less effort dedicated to the wider family of Lycopodium alkaloids. The
Lycopodium alkaloids constitute over 200 members and include increasingly complex
fused-heterocycles (Figure 1.7). The Sarpong group achieved early success with first
syntheses of the tetracyclic lyconadin A38 and lycoposerramine R,39 again using 2methoxypyridine as a masked pyridone. Subsequently, Waters synthesized (–)lyconadin C40 and Takayama completed a second synthesis of lycoposerramine-R,41
with both opting to form the pyridone ring in a semifinal step, through electrocyclic or
condensation reactions, respectively.

6

Figure 1.7 Lycopodium pyridone alkaloids
Streptomyces produce a wide variety of secondary metabolites with antitumor
and antibiotic properties. One such family are the “streptonigroids,” of which
streptonigrone was first synthesized by Boger and coworkers in 199342 and later by
Chan.43 The iromycins, isoform specific nitric oxide synthase inhibers,44 have been
synthesized by Zezschwitz et al.45 The Streptomyces derived 5-hydroxypyridone
A58365A was discovered to be a nanomolar inhibitor of angiotensin-converting
enzyme (ACE),46 an enzyme associated with cardiovascular disease. The desirability
of preventing heart disease, the leading cause of death in the United States, 47 led to
four unique total syntheses of A58365A48-51 (Figure 1.8).

Figure 1.8 Streptomyces pyridone alkaloids
Strychnine-derived pyridones have been isolated from both Strychnos nuxvomica52 and Kopsia arborea, named stryvomitine and Kopsiyunnanine-I,
respectively (Figure 1.9). Strychnine is a small vertebrate pesticide and poison, with
7

historical use dating back to 1640.53 The molecule is considered a “classic in total
synthesis,” as synthetic efforts have spanned the past 70 years. 54 Kopsiyunnanine-I
was synthesized from strychnine by Takayama and coworkers.55

Figure 1.9 Strychnine and naturally derived pyridones
The N-methoxypyridone leporin A was isolated from Aspergillius leporis, and
was shown to inhibit the growth of the corn earworm Helicoverpa zea as well as the
gram-positive bacteria Bacillus subtilis.56 It was synthesized in 1996 by Lu and Snider
in 8 steps and 4% yield.57 Another N-methoxypyridone, YCM1008A, derived from
Fusarium, was discovered to be a Ca2+ signaling inhibitor and was synthesized by
Hosokawa et al (Figure 1.10).58

Figure 1.10 N-methoxy pyridone alkaloids
4-Hydroxypyridones, typically derived from tetramic acid with a biosynthetic
oxidative ring expansion,59-61 form a class of compounds with antifungal and antitumor
properties.62 4-Hydroxypyridones include ilicicolin H, synthesized by the D’Antuono
8

group63 and sambutoxin, synthesized by Williams and coworkers (Figure 1.11). 64 The
aforementioned iromycins also fall under this classification.

Figure 1.11 4-Hydroxy pyridone alkaloids
4,N-Dihydroxypyridones include tenellin65 and its related family of antifungal
compounds,66-69 as well as the antibiotic akanthomycin.70 The antitumor drug
candidate TMC-69-6H, isolated from cultured Chrysosporium, has been synthesized
several times due to its selective phosphatase inhibition. 71-73 The atropoisomers
cordypyridone A and B are comparatively structurally simple, but have antimalarial
properties presumably due to their action as siderophores (iron transporting small
molecules). They were synthesized in concise fashion by Chai and coworkers.74
Didymellamide A, recently discovered from the marine fungi Stagonosporopsis
cucurbitacearum, displays antifungal activity against azole-resistant C. albicans.
(Figure 1.12).75

9

Figure 1.12 4,N-Dihydroxy pyridone alkaloids
Polycyclic pyridones include the bicyclic antifungal furopyridone CJ16-170,
synthesized by Che and Snider,76 and the anticancer Louisanin family, synthesized
most recently by Kaila Margrey of the Scheerer Lab. 77 The pentacyclic,
monoterepenoid indole-containing molecule naucline was recently isolated from the
bark of Nauclea officinalis, a traditional Chinese medicine (Figure 1.13).78

Figure 1.13 Polycyclic pyridone alkaloids
New pyridone natural products have been isolated periodically over the past
half century, with the past decade seeing a new family of pyridones every year. There
are, understandably, too many to list individually.79 Some recent highlights (Figure
1.14) are the arthpyrones (2015)80 and campyridones (2016),81 which are ring-fused
10

ethereal metabolites of 4-hydroxypyridones. In the same class as these are the
hypocrellutins (2018), isolated from the scale-insect pathogenic fungus Hypocrella
discoidea.82 While showing no activity in biological assays, I find hypocrellutin A
structurally beautiful.

Figure 1.14 Recently discovered pyridone natural products
Pyridone Derivatization
While present as a bioactive motif in a wide variety of natural products, the
pyridone nucleus has also been used as a starting point for many complex
compounds. N-Protected pyridones are susceptible to Diels-Alder [4+2] cycloaddition,
but their aromatic character and electron deficiency makes this process slow, with
reaction times ranging from days to a month at 100 °C.83-85 This rate can be enhanced
substantially using 3-hydroxypyridones and an alkylamine base catalyst, furnishing
only endo cycloadducts in half an hour at ambient temperatures, and in excellent
yields (Scheme 1.2).86 A chiral β-amino alcohol organocatalyst can make this reaction
enantioselective.87 Inverse-electron-demand Diels–Alder (IEDDA) reactions have
11

also been optimized to ambient temperatures, though the rate is still slow (24-48h).88

Scheme 1.2 Dramatic rate enhancement in the base-catalyzed Diels-Alder of
3-hydroxypyridones
Intramolecular [4+4] and [2+2] photodimerization of tethered dipyridones offer
a unique route to unusual 8- and 11-membered ring systems (Scheme 1.3).89,

90

Pioneered by Scott Sieburth over a couple decades and a dozen publications, the
methodology has been expanded to (tethered) furans, 91 enynes,92, 93 pyrones,94, 95
and benzenes.96 Trans or cis ring fusion (8 membered or larger) can be controlled by
solvent effects, as the molecular orientation depends on the H-bonding dimerization
of pyridones.97 The methodology was used to prepare an intermediate to taxol. 98
Intermolecular reactions are possible, but are lower yielding and less selective. 99

Scheme 1.3 [4+4] photodimerization of tethered dipyridones
Direct derivatization of 2-pyridones has been achieved at most positions. N
12

and O can be alkylated with simple SN2 chemistry, or more mildly with coupling100-102
conditions. N-Alkylation is typically dominant, especially in polar solvents with alkali
salts. O-alkyl products can be formed exclusively with the use of silver salts, nonpolar
solvents, and sterically bulky electrophiles.103 The C6 position can be accessed
through methoxymethyl (MOM) directed zincation/magnesiation104 or pyridyl-directed
Rh or Pd C-H alkylation, arylation,105 alkynylation,106 and borylation.107 Iron catalysis
furnished aryl substitution at the C3 position,108 while a gold catalyst installed an
alkyne at C5.106 These results are summarized in Table 1.
Table 1 Pyridone substitution strategies
Pyridone

Conditions
i) Alkali metal (Na, K)
ii) R-X
DMF
i) Ag2CO3
ii) R-X
benzene
Ar-I
CuI, DMCDA, K2CO3
toluene
Ar2IOTf
Cs2CO3
DCE, 120 °C
i) TMP2Zn·2LiCl·2MgCl2
THF, -10 °C, 72h
ii) Ar-I
R-BF3K
(Cp*RhCl2)2 (5 mol%)
AgSbF6 (20 mol%)
DCE 40-100 °C
R= alkyl, aryl
B2pin2
[Rh(OMe)(cod)]2 (2 mol%)
THF
13

Product

R= alkyl, H

(Cp*RhCl2)2 (5 mol%)
Zn(OTf)2 (15 mol%)
DCE 80 °C
Si-EBX
AuCl (5 mol%)
TFA
Dioxane 80 °C
ArB(OH)2
Fe(NO3)3·9H2O (10 mol%)
K2S2O8, K2CO3
1:1 DCE:H2O 70 °C
air

Synthetic Approaches to Pyridones
The synthesis of the pyridone nucleus has been a longstanding challenge
dating back to the 1920s,109 and has been reviewed on a few occasions. 4, 110 Select
recent examples of synthetic strategies will be presented in context, rather than
repeating the prior reviews.
The interconversion of 2-substituted pyridines to pyridones is a common tactic
in natural product synthesis. 2-halopyridines and 2-alkoxypyridines can be liberated
by simple hydrolysis, which is aided by the preformation of pyridinium salts. 111 Obenzyl pyridines can be cleaved at ambient temperatures by simple hydrogenation 112
or ruthenium catalyzed photoreduction.113 Demethylation of O-Me pyridines is
commonly afforded by sodium ethanethiolate (NaSEt) at elevated temperatures (120
°C) (Scheme 1.4).38

14

Scheme 1.4 Strategies to reveal masked pyridones
Condensation reactions are some of the oldest and most fundamental
reactions in organic chemistry. They were the first avenues of assembling pyridones,
via the aldol condensation and subsequent imine condensation of an α-cyano amide
with a β-diketone in the presence of piperidine (scheme 1.5).109

Scheme 1.5 Classical condensation reaction
Such reactions have been accomplished with varying synthons114 to produce
large libraries of simple substituted pyridones.115 A typical modern procedure involves
a diketone, a substituted amine, and an electron deficient alkene heated in one pot
(Scheme 1.6).116 These reactions work best when run neat with microwave heating,
which limits their scale. The necessity of electron withdrawing groups (typically esters
or nitriles) also narrows the scope to substituted pyridones. The Vilsmeier-Haack
15

reaction has been used to form pyridones in a similar fashion.117

Scheme 1.6 Modern condensation reaction
It is worth mention that N-tosylated hydropyridones can be easily deprotected
and aromatized through simple base mediated elimination (Scheme 1.7).118 This
transformation, while limited by the acidity of the C6 proton, is quantitative and very
powerful within specific contexts (such as ring closing metathesis119).

Scheme 1.7 Aromatization of N-tosyl hydropyridones
Electrocyclic ring closure of either (A) an isocyanate with an alkene or (B) an
imine with an acylketene offers a unique route to ring-fused pyridones (Scheme 1.8).
Isocyanates are typically furnished by Curtius rearrangement, historically with
trimethylsilyl azide120 and modernly with diphenyl phosphoryl azide (DPPA).121
Ketenes have been prepared by either ring-opening cyclobutanes122 or cleavage of
Meldrum’s acid derivatives.123 This chemistry has led to a variety of tri- and bicyclic
pyridones, as well as furan and thiazole fused pyridones. The major downsides are
16

potentially high temperatures required (up to 180 °C) and starting material synthesis.

Scheme 1.8 Electrocyclic ring closures of isocyanates and acyl ketenes
Metallocyclization was developed over the past couple decades for the
synthesis of pyridones. The [2+2+2] metallocyclization of dialkynes with nitriles,
isocyanates, and isothiocyanates have been reviewed previously, 124 utilizing iridium,
rhodium, and zinc. By this method, only substituted pyridones (typically alkyl) can be
made in a high yield, but thio derivatives can also be easily accessed. Other limitations
include starting material synthesis (diynes and ketene type functional groups), as well
as ligand optimization. Ollivier et al. most recently made a variant of this reaction
which is enantioselective of biaryl atropisomers. This was accomplished through a
strategy termed ‘double stereodifferentiation,’ making use of rhodium in tandem with
a chiral phosphine and a chiral silver counterion (Scheme 1.9).125 The optimization of
this reaction is relatively interesting. It progresses at room temperature (rather than
80 °C) if the Rh(cod)Cl2 catalyst is hydrogenated prior to use, as cyclooctadiene (cod)
can be reduced, leaving a more accessible active site. There is also a pre-mixing time
necessary to optimally form the chirality-transferring ion pair.
17

Scheme 1.9 [2+2+2] Metallocyclization with double stereodifferentiation
Thermal cycloaddition, where two unsaturated components form a new ring in
a concerted and energetically favorable process, is conceptually the most
straightforward route to six membered rings, with a rich history dating back to the work
by Otto Diels and Kurt Alder in the late 1920s. By definition, cycloadditions form new
σ bonds at the expense of π bonds. This means, in order to form aromatic
heterocycles via cycloaddition, it requires either two π components in the starting
materials (alkynes or equivalent), or a subsequent event that reestablishes
aromaticity (elimination or cycloreversion). The former approach, termed a dehydroDiels-Alder, has historically only been used to form benzenoids126 until very recently
when Hoye and coworkers developed a pentadehydro-Diels-Alder which produced
pyridines (Scheme 1.10).127 This approach has not been extended to pyridones, but
presumably could give a pyridone precursor (e.g. 2-alkoxypyridine) if the starting
alkyne was appropriately alkoxy-substituted. The limitations of this approach are
starting material synthesis and the required tether which leaves behind a fused 5membered ring.

18

Scheme 1.10 Pentadehydro-Diels-Alder reaction yielding pyridines
The more common approach to aromatic heterocycles via cycloaddition relies
on the formed cycloadduct containing an instability which allows for favorable,
selective cycloreversion. [3+2] Cycloaddition (involving 1,3-dipoles), has yielded
pyridones with the subsequent elimination or extrusion of one atom bridges of either
oxygen, sulfur, or nitrogen, in the cases of isomünchnones,128 thiomünchnones,129, 130
or carbanionic pyrroloimidazoles,131 respectively (Scheme 1.11). Münchnones and
derivatives are prone to rearrangement (and therefore generally low yielding), and
their synthesis can be lengthy.

Scheme 1.11 [3+2] cycloaddition/elimination of an isomünchnone
[4+2] Cycloaddition and subsequent cycloreversion is preferable to [3+2] as it
avoids charged intermediates and precursors. Additionally, the retro-Diels-Alder can
be very favorable and proceed spontaneously when the extruded two atom bridge
produces a neutral gas such as N2 or HCN, in the case of (cyclic) azines, or CO2 in
the case of oxazinones (Scheme 1.12). While this technique has been used to a great
extent by Boger and coworkers,132 the methodology is typically limited to pyridines.

19

Scheme 1.12 Diels-Alder/retro-Diels-Alder strategies for pyridines
There are relatively few examples of [4+2]/r[4+2] reactions yielding pyridones.
First is that of Sammes et al.,133 who reacted hydroxypyrazines with diesteracetylenes. The cycloadduct existed with two lactam bridges, either of which could be
extruded with heat (Scheme 1.13).

Scheme 1.13 Early [4+2]/r[4+2] strategy for pyridones from pyrazines
Sammes later expanded this methodology to derivatives of pyrimidines or
pyrazinones, but either high temperatures (150-200 °C) or strong acid (HCl) was
required to affect retro-Diels-Alder. The latter transformation was recently reported134
between electron deficient pyrazinones and alkynyl boronates, offering a favorable
route to relatively simple pyridones which can be derivatized and coupled at the C5
position (Scheme 1.14). Drawbacks include high temperature (180 °C), neat heating,
and modest yield (51-68%).

20

Scheme 1.14 Recent [4+2]/r[4+2] strategy for pyridones from pyrazinones
The other precedent is from an oxazinone by Shioiri et al.135 This oxazinone is
formed transiently from the reaction of an acyl isocyanate with a silyl ketene, and then
undergoes a Diels-Alder/retro-Diels-Alder when reacted with dienophiles (Scheme
1.15). The degree of unsaturation in the precursors limits substitution to the C4 and
C5 positions, with C6 always containing an aryl group to enable the reaction
electronics. The oxazinones were not isolated because they were prone to hydrolyze
“within a few minutes.” Still, the evolution of CO2 is a favorable process that inspires
continued interest in oxazinones.

Scheme 1.15 [4+2]/r[4+2] strategy for pyridones from oxazinones
Our lab’s efforts towards pyridones began with Kaila Margrey.136 First, glycine
or proline derived diketopiperazines containing a lactim O-methyl ether were
synthesized in four steps and moderate yield. They were then reacted with an
aromatic aldehyde containing an alkyne tether, in an aldol condensation. The
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resultant exocyclic alkene could be isomerized into the ring with an organic base,
transiently forming a pyrazinone which would undergo a Diels-Alder at 100 °C. The
produced cycloadduct contained a lactim o-methyl ether which was too stable for
retro-Diels-Alder (up to 200 °C). Following demethylation and acetylation, the now
imide bridge was extruded at temperatures conveniently accessed through
microwaved toluene (~200 °C), furnishing tri- and tetracyclic pyridones (Scheme
1.16).

Scheme 1.16 Scheerer lab strategy for pyridones from diketopiperazines
Conclusion
2-Pyridone is a unique structural motif that occurs naturally in a wide variety of
pharmacologically relevant natural products. The desirability of these natural products
has driven synthetic interest in pyridones for the past 70 years. Synthesis and
derivatization of pyridones remains challenging due to its unique physical and
electronic properties. While there are methods of synthesizing pyridones, each has
its advantages and disadvantages. Diels-Alder/retro-Diels-Alder processes have low
reaction thresholds and can quickly furnish polycyclic heterocycles. There are few
examples of [4+2]/r[4+2] processes yielding pyridones, so we sought to improve on
the Margrey synthesis.
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Chapter 2
Development of a One Pot [4+2]/r[4+2] 2-Pyridone Synthesis
Reaction Development
Inspired by the Margrey precedent, we sought to create a more expedient route
to similar tricyclic pyridones starting from commercially available materials. We began
with an aldol condensation between a simple diketopiperazine 1 and an aromatic
alkynylbenzaldehyde, yielding 2. From there, we envisioned trapping the lactam as
lactim ether 3, and afterwards isomerizing the exocyclic alkene into the ring to form
pyrazinone 4. Precedented cycloadditions with pyrazinones led us to be confident that
4, if formed, would spontaneously react intramolecularly with the alkyne tether,
forming 5 in a Diels-Alder [4+2] cycloaddition. We believed we could then selectively
extrude one of the bridges of 5 in a retro-Diels-Alder reaction, to yield tricyclic pyridone
6 (Scheme 2.1).

Scheme 2.1 One pot reaction plan
To this end, we made diacetyldiketopiperazine 1 by the quantitative bisacetylation of glycine anhydride using acetic anhydride. For the other reactant, we
performed our initial studies with the commercially available 2-ethynylbenzaldehyde
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7, but later expanded to a variety of alkynyl-substituted benzaldehydes through known
Sonogashira couplings (Scheme 2.2).1 Coupling materials, aside from catalysts used
at 4-7 mol%, were typically a few dollars per gram.

Scheme 2.2 Starting material synthesis
With starting materials in hand, we attempted the sequence stepwise. To our
pleasant

surprise,

the

aldol

condensation

was

quite

facile

with

1,8-

diazabicyclo[5.4.0]undec-7-ene (DBU) in dimethylformamide (DMF) at room
temperature, owing to the imide functionality (Scheme 2.3). In contrast, the Margrey
precedent required the stronger lithium hexamethyldisilazide (LiHMDS).

Scheme 2.3 Initial success in the aldol condensation
The reaction predominantly forms the kinetically favored and desired Z alkene
8, though it can isomerize up to 10% of the E isomer if allowed to react longer than
the required 1-1.5h reaction time (e.g., overnight). The first attempt was exceptional,
34

isolating the aldol product in 93% yield (7 mmol scale), after it precipitated out of the
workup solution due to its poor solubility in EtOAc. This ended up being quite difficult
to replicate, as too little EtOAc would carry through the small percentage of E isomer,
and too much EtOAc would precipitate less and give a low yield. It was crucial that
the aldol product be isolated upon workup, as recrystallization turned out to be
difficult2 and column chromatography was low yielding (~30%), due to low solubility
in EtOAc and high polarity. We found that the inorganic base Cs2CO3 also worked
well and allowed us to avoid acidic workup. A reaction mixture of 1:1 DMF:toluene
gave reliable precipitation upon dilution with Et2O/di-H2O, and the crystals were rinsed
with the same mixture. This optimized procedure gave the pure Z isomer in 85% yield,
and this yield proved typical upon replication (Scheme 2.4). The procedure is quite
general and has been applied to other diketopiperazine aldol products in our
laboratory.

Scheme 2.4 Optimized aldol condensation
Attempts to form and isolate a lactim ether were not successful. A variety of
silylating

agents

were

hexamethyldisilazane

tried,

(HMDS),

such

as

di-tert-butyldichlorosilane

bis(trimethylsilyl)acetamide

(BSA),

(TBSCl),
and

tert-

butyldimethylsilyl trifluoromethanesulfonate (TBSOTf). It is reasonable to assume the
lactim o-silyl ether products were formed but hydrolyzed back to starting material upon
workup. Meerwein’s salt (trimethyloxonium tetrafluoroborate) was used to form the
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lactim o-methyl ether. This was marginally successful, but mass recovery and
subsequent isolated yield were unacceptably low (<30%) (Scheme 2.5).

Scheme 2.5 Attempts to isolate lactim ethers
Next, we paired a silylating agent with a base to avoid isolating the lactim osilyl ether and promote alkene isomerization and subsequent Diels-Alder. With DBU
as a base and BSA as a silylating agent in DMF at 120 °C, we were surprised to find
that the isolated product was not the cycloadduct 9, but the cycloreversion product 10
(entry 1). This prompted further investigation which is summarized in Table 2.1.

36

Table 2.1 Diels-Alder/retro-Diels-Alder optimization
Refluxing toluene (110 °C) offered similar results to DMF at 120 °C, allowing
us to avoid working with high boiling DMF (entry 2). When the reaction was run with
temperature increasing in increments, no reaction was observed until 85 °C (block
setting), which consumed starting material and gave a new spot by TLC. This turned
out to be the cycloadduct 9 (entry 3). The inorganic base Cs2CO3 deacylated the imide
bridge at elevated temperatures, leading to no desired products (entry 4). Later, we
discovered that using the weak base triethylamine (NEt3) afforded only the
cycloadduct at 120 °C (entry 5). We doubted that NEt3 was really required, but studies
without it showed no reaction (entry 6). Substoichiometric amounts of DBU gave a
mixture of the two products, meaning that at least one equivalent of DBU was required
to affect the retro-Diels-Alder (entry 7).
The yield for entry 5 was variable. BSA could cause up to 15% of byproducts
related to acetamide. In the cases where these were acceptably low (>95% purity),
37

the cycloadduct did not need to be purified and yield would reach 90%. Other attempts
required purification, which decreased the yield to ~60-80%, as there was a degree
of degradation on the column. This issue was avoided by switching to
chlorotrimethylsilane (TMSCl), as its only byproduct is gaseous HCl. Use of TMSCl
lead to quantitative formation of cycloadduct 9 (entry 8), and cleaner production of 10
(entry 9). This result should not be understated. Typically, TMSCl and alkylamines
such as NEt3 are only used freshly distilled. Both of the reagents were always used
out of a bottle for this work, which is why higher equivalents of each were used. Less
reagent (2 equiv TMSCl, 3 equiv NEt3) worked fine if fresh, but the fact that these
reactions work just as well with old TMSCl and NEt3 speaks to their robustness and
ease of replication.
The low yield of the retro-Diels-Alder requires elaboration. The reaction was
run fifteen different times with varying amounts of reagents, reaction time, workup,
and purification/derivatization techniques. Nothing improved the situation, which in
retrospect, was caused by the unfortunate physical properties of pyridone 10. By
typical procedure, pyridone 10 is isolated in reasonable mass recovery (<70%) with
~30% DBU-related impurities. It can be purified, but due to its polarity and poor
solubility it tends to adhere to a CHCl3/MeOH column. Even in the most optimized
conditions, this translates to a <30% isolated yield. There is also always a large
amount of black powder precipitate isolated during workup. The black powder is
effectively insoluble in all but the most polar and high boiling solvents such as DMF
and dimethylsulfoxide (DMSO). Initially it appeared as if this was an insoluble
pyridone hydrate dimer, as it constituted over 100% mass recovery while appearing
to be pure 10 (with water) in deuterated DMSO 1H NMR spectroscopy. Repeated,
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excessive washings of the precipitate with EtOAc removed 10 from the solid. The
precipitate alone appeared polymeric.3 Pyridones are known to polymerize near their
melting point (190-210 °C);4 While temperatures do not reach this high, base
promoted polymerization is not uncommon,5 especially with strong organic bases
such as DBU.6
Due to the difficulty of recovering pure pyridone from the Diels-Alder/retroDiels-Alder, our attention shifted to probing the reactivity of the retro-Diels-Alder in
isolation. To this end, cycloadduct 9 was produced in large scale and subjected to
varied conditions (Table 2.2).

Table 2.2 Optimization of the retro-Diels-Alder
It was immediately apparent from these reactions that greater than an
equivalent of DBU was required, but that there was no real difference in rate observed
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for a moderate excess (entry 1), which was used when convenient (e.g., small scale).
Vast excesses of DBU yielded no product (entry 2). DBU at higher temperatures
(entry 3) produced 10 but with a minor decrease in purity. Weaker bases (entry 4, 5)
did not affect retro-Diels-Alder, even under forcing conditions. The threshold for retroDiels-Alder is higher than in the Margrey precedent, as only pure starting material was
observed after heating to 200 °C in toluene in the microwave (entry 6). Heating 9
directly on a hotplate at 200 °C afforded 10 but with impurities and the insoluble
polymer (entry 7). The presence of silylating reagent (one pot conditions) made
minimal difference as long as there was excess base (entry 8).
As the DBU based optimization studies seemed to reach a dead end, we
sought to screen a wide range of reagents which could potentially promote the retroDiels-Alder (Table 2.3). Included in this table is the isomeric impurity 10i which is
caused via acyl transfer. This impurity is formed in ~20% conversion when heated
neat (i.e., thermally).
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Table 2.3 Retro-Diels-Alder reaction screening
Refluxing pyridine, even when used as the solvent, returned starting material
(entry 2). Subjecting 9 to acidic conditions via acetic acid or trifluoroacetic acid (entry
3, 4) also returned starting material. The Lewis acids scandium triflate and copper
triflate (entry 5, 6) primarily deacylated the material, but also produced a byproduct
which we were not able to identify. This byproduct was red in visible light but
constituted only a few mass%, and was therefore difficult to characterize. The strong
base sodium hydride (entry 7) afforded a 1:1 mixture of 10 and 10i. This was quite
impure but occurred at a lower temperature than DBU (80 °C). The strong base
LiHMDS (entry 8) gave only very impure, trace product. 7-Methyl-1,5,7triazabicyclo[4.4.0]dec-5-ene (MTBD), a base 1.5 pKa units stronger than DBU, also
afforded a 1:1 mixture at 80 °C and a comparable result to DBU at 110 °C (entry 9).
The phosphazene base tert-butylimino-tri(pyrrolidino)phosphorene (BTTP), a base
4.5 pKa units higher than DBU, only deacylated the material at 60 °C, but afforded
the desired product 10 at 110 °C (entry 10). However, the phosphazene proved
inseparable from 10 via chromatography.
At this point in the investigation, it had been a couple years of part-time effort
as an undergraduate student. Having accepted the poor yield of the retro-Diels-Alder
as a fact of life, a final effort was made to couple the aldol condensation with the other
steps, such that the chemistry would be more convenient to replicate. Considering the
first two steps are nearly quantitative, the expected 27% yield over 3 steps translated
into an average ~65% yield per step, which is respectable enough to report in the
literature. Much to our surprise, including the aldol condensation in the one pot
process gave a 67% overall yield (Scheme 2.6).
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Scheme 2.6 Unexpectedly high yielding one pot process
The work-up for this reaction began typically, by diluting the reaction using
EtOAc and quenching with an appropriate amount of 0.1M HCl. However, during the
subsequent Büchner filtration, the black solid precipitate was non-existent, and
seemingly all of the product washed through the filter pad. The crude residue
contained only minor impurities, and was clean enough to use without purification,
affording a 67% yield upon replication. It is important to note that a small amount of
precipitate appeared after neutralization with NaHCO3. This solid was the less soluble
impurity 10i, which constituted 20% conversion by mass. When the reaction was
replicated with additional DMF added during workup, 10i was solvated and the
reaction afforded an 88% yield with a 5:1 mixture of 10:10i. Though 10i was not found
during stepwise DBU experiments, the high yield of 10 and the ease of avoiding 10i
during workup is preferable.
Efforts to understand why the one pot process is cleaner than the stepwise
reaction, and why polymeric material is formed during the stepwise reaction, have not
been successful. As previously mentioned, silylating reagents have no effect on the
retro-Diels-Alder. Therefore, the only principal difference between the one pot and
stepwise processes is the elimination of acetate during the aldol condensation.
Attempting the retro-Diels-Alder with an equivalent of acetic acid and excess DBU
(i.e., DBU buffered acetate), showed no difference from other stepwise r[4+2]
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attempts. Though the one pot must use DMF to solvate DKP 1, the retro-Diels-Alder
has been previously shown to behave identically in either DMF or toluene.
Substrate Scope
With a functional one pot [4+2]/r[4+2] 2-pyridone synthesis in hand, our efforts
turned to examining the substrate scope (Table 2.4).

Table 2.4 One pot substrate scope
Alkyl substituents were used to test the reaction’s sensitivity to steric bulk on
the alkyne. The resulting substrates (entry 1, 2) were much more soluble than 10 (R=
H), and were purified after workup using a CHCl3/MeOH flash column. The n-butyl 19
(entry 1) was formed in fair yield (52%), while the t-butyl 20 (entry 2) was isolated in
very good yield (81%). This shows that there is little effect of steric bulk on the
reaction. The lower yield of the n-butyl substrate suggests possible degradation
through reaction at the saturated alkynyl position. Ethereal substrates (entry 3, 4)
appeared to progress normally by TLC, but no product was isolated. Likewise, phenyl
43

substitution (entry 5) showed apparent progression by TLC, but did not yield 23. TMS
(entry 6) progressed to the pyridone, but the silicon was not stable in the product and
only 10 was isolated. The pyridine substituent did not progress by TLC (entry 7).
Finally, the (CH2)2Ph substituent (entry 8) was not used as it was deemed too similar
to the alkyl substrates to make a meaningful contribution towards understanding the
reactivity.
Due to the apparent reaction progression of the unsuccessful substrates, a
modified one pot procedure was developed to quickly access the cycloadduct
structures (Table 2.5).

Table 2.5 Modified one pot procedure to produce cycloadducts
The formed cycloadducts were all normally soluble amorphous (foam-like)
compounds purified via EtOAc/hexanes flash chromatography. The previously
investigated 7 (entry 1) was used to provide a baseline of expected yield, given that
the cycloadducts experience some decomposition during chromatography due to their
acid sensitivity. Tetrahydropyranyl (THP) ether 13 formed cycloadduct 26 in moderate
yield (50%, entry 2), while the benzyl ether 14 formed cycloadduct 27 in good yield
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(65%, entry 3). This difference can be attributed to the acid sensitivity of THP, which
also existed as a pair of diastereomers due to the chirality of THP. The phenyl
substituted 15 formed cycloadduct 28 in decent yield (67%, entry 4). This process
was rather slow (24h) and had the unusual event of acyl transfer, with both bisacetylated material and deacetylated material being isolated. These byproducts
constituted ~10% yield each. The TMS aldehyde 16 gave cycloadduct 29 in moderate
yield (55%), as well as desilylated cycloadduct 9 (11%) (entry 5). The desilylated
material was present in the crude reaction mixture and was not an artifact of
chromatography. The 2-pyridyl aldehyde 17 was surprisingly unreactive, only forming
the aldol condensation product 30 (entry 6).
Treatment of each isolated cycloadduct with DBU had varying effectiveness at
promoting retro-Diels-Alder. In examining the propargylic substrates, the THP
substrate 26 showed initial promise in r[4+2], but interpretation was complicated by
the presence of diastereomers. The benzyl ether 27, being more stable and higher
yielding in the prior step, was used instead. Conventional heating of 27 with DBU
afforded pyridone 22 in acceptable yield (49%, Scheme 2.7).

Scheme 2.7 r[4+2] of an ethereal substituted cycloadduct
Cycloreversion of the phenyl substituted cycloadduct 28 proceeded rather
poorly with DBU and conventional heating, and was twice as slow as other reactions.
Peculiarly, no desired products were isolated if greater than one equivalent of DBU
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was used. Doubling the concentration (0.1M -> 0.2M) improved the reaction rate to
be within a day. Heating the reaction in the microwave at 200 °C accomplished the
reaction within an hour, but with increased formation of the undesired isomer 23i. The
isolated yields for conventional heating and microwave heating were 16% and 25%,
respectively (Scheme 2.8).

Scheme 2.8 r[4+2] of a phenyl substituted cycloadduct
The TMS substituted cycloadduct 29 reacted similarly to the one pot conditions
upon treatment with DBU. Retro-Diels-Alder occurred in high conversion but only
desilylated pyridone 10 was isolated (Scheme 2.9).

Scheme 2.9 r[4+2] of a TMS substituted cycloadduct
The 2-pyridyl aldol condensation product 30 would not undergo [4+2] DielsAlder cycloaddition even under forcing conditions, only degrading the compound
(Scheme 2.10). Previous optimization studies of the [4+2] of 8 produced no desired
products when heated to 200 °C in the microwave, so this was not attempted for this
substrate.
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Scheme 2.10 Unsuccessful [4+2] of a pyridyl substituted aldol product
Unsuccessful Substrates
Having successfully synthesized tricyclic pyridones, our attention turned to
substituent effects on the diketopiperazine starting material (Scheme 2.11). We
hypothesized that substitution would increase the rate of reactivity. Additionally, this
would offer substitution at the C3 position.

Scheme 2.11 Substituted diketopiperazine starting material synthesis
p-Anisaldehyde 31 was a convenient substituent as it is cheap and UV active.
After a typical aldol condensation yielding 32, the free amide on the diketopiperazine
was acetylated using acetic anhydride and the exocyclic alkene was reduced via
hydrogenation, producing racemic 33. This substrate served as a substituted
diketopiperazine model system. Afterwards, another standard aldol condensation
yielded 34. The aldehyde used in this reaction was 7 so that the alkynyl tether could
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be utilized in later Diels-Alder chemistry. Yields were typical and not optimized;
acetylation and hydrogenation were expectedly quantitative.
Attempts to transiently form a pyrazinone and affect Diels-Alder of 34 failed in
a similar manner to the pyridyl substrate (Scheme 2.12).

Scheme 2.12 Unsuccessful [4+2] of a diketopiperazine substituted aldol product
Initial subjection of 34 to typical refluxing toluene conditions returned only
starting material. Incremental increases in heating created only further impurities and
no desired product 35. The material was heated in a sealed tube at 130 °C, then a
microwave at 170 °C, and finally a microwave at 200 °C.
Enolizable (that is, aliphatic) aldehydes have been used in one pot Diels-Alder
processes previously by our lab.7 The aldol condensation proceeded normally and
formed 37, but subsequent cycloaddition attempts failed. Attempted reaction in
refluxing toluene afforded zero conversion, so the material was resubmitted in DMF
at 150 °C. This reaction formed only the enolate derived byproduct 38 (Scheme 2.13).
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Scheme 2.13 Aliphatic aldehydes produce an undesired byproduct
Synthesizing the volatile starting aldehyde 36 was problematic in my hands
and prevented further study. Having referenced its reported boiling point at various
pressures (50 °C at 15 torr, 90 °C at 80 torr), and consulted a pressure-temperature
nomograph, the rotory evaporator was set accordingly low enough temperature and
pressure so as to only evaporate solvents (23 °C, 20 torr). Distilling the aldehyde
directly was not fruitful. Dess-Martin oxidation followed by a column of low boiling
diethyl ether/pet ether resulted in very low mass recovery. A more conservative
approach was attempted using Parikh–Doering oxidation and avoiding rotary
evaporation. Fractions of a column of diethyl ether/pentanes were allowed to sit at
room temperature for two days, during which time the solvents expectedly
evaporated, but the aldehyde did as well. Having lost nearly 35 mmol of material, it
seemed wise to discontinue this substrate.
Expanding the Scope
We next sought to expand the reaction scope to include 6,6,6 tricyclic
pyridones, azaanthracenes (Scheme 2.14).
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Scheme 2.14 Azaanthracene reaction plan
The additional carbon in the starting aldehyde 39 possesses a propargyl ether
which allowed for a straightforward synthesis of the starting material. We assumed
the aldol condensation to 40 and Diels-Alder to 41 would be relatively straightforward.
Retro-Diels-Alder would proceed with aromatization via elimination of alcohol, yielding
42.
The most expedient route to the starting aldehyde ended up being four steps
(Scheme 2.15).

Scheme 2.15 Starting material synthesis for 6,6,6 tricyclic pyridones
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The first step followed literature precedent,8 using the inexpensive and
commercially available 43 and affording 44 with 88% yield at a 22 mmol scale. The
following Grignard addition required 1.5 equivalents of commercially available
ethynylmagnesium bromide and formed 45 in 80% yield following chromatography.
Initial studies were performed with an acetate protected alcohol, but downstream
products ended up being too insoluble to manipulate easily. The aliphatic nature of a
tert-butyldimethylsilyl (TBS) ether allowed these latter products to be soluble in typical
organic solvents. NEt3, TBSCl, and 4-dimethylaminopyridine (DMAP) in methylene
chloride was first used to install the TBS group, but it required purification and was
lower yielding than expected (52%). Corey’s conditions9 (TBSCl with imidazole in
DMF) proved superior, furnishing 46 cleanly and in high yield (95%). Cleavage of the
acetal to afford 47 is facile in a range of acidic conditions. It was first accomplished
with a mixture of HCl in THF and later with pyridinium p-toluenesulfonate (PPTS) or
p-toluenesulfonic acid (TsOH) in acetone. TsOH proved to be the quickest and
cleanest of these. Though it is a catalyst, 0.5 equivalents of TsOH proved convenient
because it accomplished complete conversion to 47 in forty minutes; it is essential to
form and use 47 quickly as the produced aldehyde is not stable. In total, 47 was
produced in 66% yield over four steps, with only one chromatographic separation
required after the Grignard addition. Typically, the last two steps and the subsequent
aldol condensation were run within the same day.
With starting material in hand, the reaction sequence was attempted beginning
with the aldol condensation. From the aldol product, various one pot conditions were
tried but did not yield desired products and were difficult to interpret. Best results came
from the stepwise sequence (Scheme 2.16).
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Scheme 2.16 Stepwise sequence to azaanthracene
Aldehyde 47 was reacted with 1 using Cs2CO3 as base in DMF. A mixture of
toluene and DMF was not used because the aldol condensation product 48 was too
soluble to precipitate readily. Instead, it was purified by chromatography in a 49%
yield. O-silylation, alkene isomerization, and Diels-Alder appeared to have a higher
activation energy than previous substrates, as no reaction was observed under typical
conditions in refluxing toluene. A sealed tube at 130 °C with excess reagents and a
day of reaction time was required for it to go to completion. Heating to this higher
temperature forms triethylamide, a byproduct from deacylation caused by
triethylamine. This necessitated purification by chromatography, affording 49 in a 66%
yield. Cycloadduct 49 proved unstable, degrading over a few days if left at room
temperature. Retro-Diels-Alder also had a higher activation barrier than prior
experiments, with no reaction observed using DBU in refluxing toluene. Microwaving
the same mixture to 200 °C formed azaanthracene 50 with a minor amount of isomeric
product (10-20%). Chromatography gave 50 in a 62% yield. 5 equivalents of DBU
allowed this transformation to occur in an hour. Due to prior studies showing no
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significant difference in DBU excess on the rate of retro-Diels-Alder, it is presumed
that the higher equivalents of base speed the reaction by hastening the elimination of
silanol. Overall, azaanthracene 50 was synthesized in a 7-step linear sequence of
13% yield, an average yield of 75% per step. While the spectroscopic data is
consistent with a 6,5,6 azaanthracene, the NMR spectra in DMSO-d6 does not match
that reported in the literature.10 A crystal structure is required to determine if this work
produced a regioisomeric product or if the literature is erroneous.
Conclusion
A one pot Diels-Alder/retro-Diels-Alder process was developed to quickly
synthesize tricyclic pyridones from cheap and commercially available starting
materials. Exploration of the substrate scope revealed that alkyl substituents
performed well and that steric strain did not play a large role in the process.
Problematic substrates were subjected to a modified one pot process to form the
desired cycloadducts. These cycloadducts were then converted to the corresponding
pyridones under individualized conditions. Some substrates were not fruitful, such as
the pyridyl substituted aldehyde, a substituted diketopiperazine, and an aliphatic
aldehyde. Expansion of the reaction scope to 6,6,6 tricyclic ring structures furnished
azaanthracene with only slight modification of each step.
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Experimental
General procedure A: aldol condensation / alkene isomerization / Diels-Alder
cycloaddition / retro-Diels-Alder cycloreversion
To a solution of 1,4-diacetylpiperazine-2,5-dione (1 equiv, 0.56-2.3 mmol) in DMF (0.1
M) was added benzaldehyde (1.05 equiv) followed by DBU (1 equiv). The solution
was stirred until consumption of starting material (1-3 h). Additional DBU (5 equiv)
was added followed by TMSCl (4 equiv), and the reaction was heated to 120°C until
consumption of the cycloadduct intermediate (16-24 h). The reaction was cooled to
rt, diluted with EtOAc (30 mL), transferred to a separatory funnel, and quenched with
HCl (1 M, 1-10 mL). The aqueous layer was extracted with EtOAc (3 x 10 mL). The
combined organic layers were neutralized with NaHCO3 (10-50 mL), washed with
brine (10-50 mL), dried with Na2SO4, filtered, and concentrated in vacuo. The resulting
residue was purified by flash column chromatography on silica gel.

General procedure B: aldol condensation / alkene isomerization / Diels-Alder
cycloaddition
To a solution of 1,4-diacetylpiperazine-2,5-dione (1 equiv, 0.13-1.5 mmol) in DMF (0.1
M) was added benzaldehyde (1.05 equiv) followed by DBU (1 equiv). The solution
was stirred until consumption of starting material (1-12 h). NEt3 (5 equiv) was added
followed by TMSCl (4 equiv), and the reaction was heated to 120 °C until consumption
of the aldol condensation intermediate (2-24 h). The reaction was cooled to rt, diluted
with EtOAc (10 mL), transferred to a separatory funnel, and partitioned between
diH2O (10 mL). The aqueous layer was extracted with EtOAc (3 x 10 mL). The
combined organic layers were washed with brine (30 mL), dried with Na2SO4, filtered,
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and concentrated in vacuo. The resulting residue was purified by flash column
chromatography on silica gel.

(Z)-1-acetyl-3-(2-ethynylbenzylidene)piperazine-2,5-dione (8).
To a solution of 1 (320 mg, 1.62 mmol) in 1:1 DMF/PhMe (5.4 mL, 0.3 M) was added
7 (210 mg, 1.62 mmol) and Cs2CO3 (554 mg, 1.70 mmol). The reaction was stirred
until consumption of the aldehyde was observed as judged by TLC (1.5 h). The
reaction mixture was diluted with 1:1 Et2O/diH2O (10 mL) and filtered, and the filter
pad was washed successively with additional H2O and Et2O. The resulting
condensation product 8 (370 mg, 1.38 mmol, 85% yield) was afforded as a yellow
solid that was used without further purification: mp 189-191 °C; TLC (60%
EtOAc/hexanes) Rf = 0.67 (UV, KMnO4); IR: 1683, 1631, 1369, 1254, 756 cm−1; 1H
NMR (400MHz, CDCl3): δ 7.80 (br s, 1H), 7.63 (d, J = 7.8 Hz, 1H), 7.42 (m, 4H), 4.52
(s, 2H), 3.41 (s, 1H), 2.68 (s, 3H), 1.55 (s, 1H);

13C

NMR (100 MHz, DMSO-d6): δ

172.4, 162.5, 161.2, 135.8, 133.2, 129.4, 129.2 128.9, 128.8, 122.7, 116.1, 86.7, 82.1,
46.2, 27.3; MS (ES) calcd for C15H12N2O3Na [M + Na]+ 291.0740, found 291.0738.
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(3S*,9aS*)-11-acetyl-3,4,4a,9-tetrahydro-3,9a-(epiminomethano)indeno[2,1b]pyridine-2,10(1H)-dione [Not chiral non racemic] (9).
To a solution of 8 (0.500 g, 1.87 mmol), in PhMe (10.4 mL, 0.18 M) was added NEt 3
(944 mg, 9.33 mmol) followed by TMSCl (811 mg, 7.46 mmol). The reaction was
heated to reflux (110°C) for 20 h. After cooling to rt, the reaction mixture was diluted
with diH2O (30 mL) and extracted with EtOAc (30 mL). The organic layer was removed
and the aqueous layer was extracted with additional EtOAc (5 x 20 mL).

The

combined organic layers were washed with brine (30 mL), dried with Na2SO4, filtered,
and concentrated in vacuo to afford cycloadduct 9 (0.495 g, 1.85 mmol, 99% yield) as
a pure, amorphous yellow solid: TLC (60% EtOAc/hexanes) Rf = 0.63 (UV, CAM); IR:
1697, 1369, 1333, 1244, 752 cm−1; 1H NMR (400MHz, CDCl3): δ 8.90 (br s, 1H), 7.44
(d, J = 7.4 Hz, 1H), 7.38 (d, J = 3.9 Hz, 2H), 7.30 (m, J = 7.8 Hz, 1H), 4.19 (d, J = 18
Hz, 1H), 3.18 (d, J = 18 Hz, 1H), 2.51 (s, 3H);

13C

NMR (100 MHz, CDCl3): δ 170.8,

169.3, 168.5, 156.1, 145.2, 132.5, 131.2, 128.1, 126.1, 123.0, 117.0, 70.4, 57.5, 32.7,
25.4; MS (ES) calcd for C15H12N2O3Na [M + Na]+ 291.0740, found 291.0739.

1,9-dihydro-2H-indeno[2,1-b]pyridin-2-one (10).
To a solution of 9 (16.5 mg, 0.062 mmol) in PhMe (0.9 mL, 0.07 M) was added DBU
(49 mg, 0.32 mmol). The reaction was heated to 110 °C for 4.5h. After cooling to rt,
the reaction mixture was diluted with Et2O (5 mL), quenched with HCl (0.2 M, 5 mL),
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and extracted with EtOAc (5 mL). The organic layer was removed and the aqueous
layer was extracted with additional EtOAc (5 x 5 mL). The combined organic layers
were washed successively with NaHCO3 (10 mL) and brine (10 mL), dried with
Na2SO4, filtered, and concentrated in vacuo. The pure compound 10 (3 mg, 0.016
mmol, 27% yield) was obtained following flash column chromatography on silica gel
(elution: 2% to 7% MeOH in CHCl3) as a brown solid. mp 209-211 °C; TLC (5%
MeOH/CHCl3) Rf = 0.18 (UV, KMnO4); IR (film) cm-1 1636, 1470, 773 cm−1; 1H NMR
(400MHz, CDCl3): δ 12.05 (br s, 1H), 7.75 (dd, J = 5.5, 3.5 Hz, 1H), 7.64 (d, J = 5.5
Hz, 1H), 7.52 (d, J = 6.6 Hz, 1H), 7.44 (m, J = 5.5, 3.5 Hz, 2H), 6.83 (d, J = 6.2 Hz,
1H), 3.90 (s, 2H);

13C

NMR (100 MHz, CDCl3): δ 163.1, 152.8, 145.0, 139.9, 134.3,

130.5, 128.8, 126.9, 125.3, 121.5, 101.0, 35.2; MS (ES) calcd for C12H9NONa [M +
Na]+ 206.0576, found 206.0577.

1,9-dihydro-2H-indeno[2,1-b]pyridin-2-one (10).
Produced according to general procedure A with 1 (461 mg, 2.33 mmol) and 7 (318
mg, 2.44 mmol). The extracted organic residue afforded compound 10 (286 mg, 1.56
mmol, 67% yield) as a brown solid which did not require further purification.

4-butyl-1,9-dihydro-2H-indeno[2,1-b]pyridin-2-one (19).
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Produced according to general procedure A with 1 (111 mg, 0.56 mmol) and 11 (110
mg, 0.59 mmol). The pure compound 19 (70 mg, 0.29 mmol, 52% yield) was obtained
following purification by flash column chromatography on silica gel (elution: 2% to 7%
MeOH in CHCl3) as a brown solid: mp 173-175 °C; TLC (5% MeOH/CHCl3) Rf = 0.18
(UV, KMnO4); IR: 2950, 2926, 2862, 2360, 1666, 1371, 1327, 1248, 738 cm −1; 1H
NMR (400MHz, CDCl3): δ 13.18 (br s, 1H), 7.90 (m, 1H), 7.66 (m, 1H), 7.43 (m, 1H),
7.27 (s, 2H), 3.89 (s, 2H), 2.87 (t, ` 7.4 Hz, 2H), 1.67 (m, J = 7.4 Hz, 2H), 1.47 (m, J
= 7.4 Hz, 2H), 0.97 (t, J = 7.4 Hz, 3H);

13C

NMR (100 MHz, CDCl3): δ 162.5, 151.7,

145.5, 140.6, 132.0, 131.1, 128.2, 126.9, 125.3, 124.0, 118.1, 35.3, 31.7, 30.1, 22.3,
14.0; MS (ES) calcd for C17H17NONa [M + Na]+ 262.1202, found 262.1203.

4-(tert-butyl)-1,9-dihydro-2H-indeno[2,1-b]pyridin-2-one (20).
Produced according to general procedure A with 1 (118 mg, 0.59 mmol) and 12 (116
mg, 0.62 mmol). The pure compound 20 (114 mg, 0.48 mmol, 81% yield) was
obtained following purification by flash column chromatography on silica gel (elution:
20% to 60% EtOAc in hexanes then 1% to 8% MeOH in CHCl3) as a brown solid. mp
238-240 °C; TLC (5% MeOH/CHCl3) Rf = 0.34 (UV, KMnO4); IR: 2957, 2359, 1648,
743 cm−1; 1H NMR (400MHz, CDCl3): δ 13.17 (br s, 1H), 8.23 (m, 1H), 7.67 (m, 1H),
7.47 (s, 1H), 7.44 (m, 2H), 3.92 (s, 2H), 1.57 (s, 9H);

13C

NMR (100 MHz, CDCl3): δ

162.3, 151.5, 146.1, 140.1, 133.1, 129.5, 127.9, 127.7, 126.9, 126.3, 125.2, 35.6,
33.4, 30.8; MS (ES) calcd for C16H17NONa [M + Na]+ 262.1202, found 262.1203.
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6-fluoro-1,9-dihydro-2H-indeno[2,1-b]pyridin-2-one (SI-1).
Produced according to general procedure A with 1 (500 mg, 2.52 mmol) and 2ethynyl-4-fluorobenzaldehyde (392 mg, 2.65 mmol). The extracted organic residue
(249 mg, 1.24 mmol, 47% yield) afforded the compound SI-1 as a tan solid with 20%
isomer by NMR. A small amount of sample was recrystallized with hot EtOAc for
analytical purposes. mp 226-228 °C; TLC (10% MeOH/CHCl3) Rf = 0.25 (UV,
KMnO4), IR: 3252, 2854, 1654, 1613, 1472, 1324, 1180, 1024, 780, 611 cm−1; 1H
NMR (400 MHz, DMSO-d6): δ 11.63 (s, 1H), 7.81 (dd, J = 9.0 Hz, 2.4 Hz, 1H), 7.65
(dd, J = 8.4 Hz, 5.3 Hz, 1H), 7.49 (d, J = 6.7 Hz, 1H), 7.25 (m, 1H), 6.88 (d, J = 6.7
Hz, 1H), 3.70 (s, 2H);

13C

NMR (100 MHz, DMSO-d6): δ 161.8, 160.6, 150.1, 142.1,

140.2, 135.2, 131.9, 126.5, 115.1, 108.7, 99.3, 34.5; MS (ES) calcd for C12H8FNONa
[M + Na]+, 224.0482. Found 224.0483.

(3S*,9aS*)-11-acetyl-4-phenyl-3,9-dihydro-3,9a-(epiminomethano)indeno[2,1b]pyridine-2,10(1H)-dione [Not chiral non racemic] (28).
Produced according to general procedure B with 1 (143 mg, 0.72 mmol) and 15 (156
mg, 0.76 mmol). The pure compound 28 (166 mg, 0.48 mmol, 67% yield) was
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obtained following purification by flash column chromatography on silica gel (elution:
10% to 60% EtOAc in hexanes) as a white amorphous solid. TLC (40%
EtOAc/hexanes) Rf = 0.23 (UV, CAM); IR (film) cm-1 3200, 3050, 2350, 1702, 1330,
1245, 751, 698 cm−1; 1H NMR (400MHz, CDCl3): δ 9.14 (br s, 1H), 7.56 (m, J = 7 Hz,
3H), 7.45 (t, J = 7 Hz, 2H), 7.41 (q, J = 7 Hz, 1H), 7.32 (m, J = 7 Hz, 2H), 7.12 (t, J =
7 Hz, 1H), 6.23 (s, 1H), 4.16 (d, J = 17.7 Hz, 1H), 3.28 (d, J = 17.7 Hz, 1H), 2.57 (s,
3H);

13C

NMR (100 MHz, CDCl3): δ 171.6, 171.6, 171.6, 169.6, 168.2, 146.7, 145.3,

134.1, 134.0, 133.0, 130.9, 129.3, 129.0, 128.0, 127.6, 126.1, 123.1, 71.1, 62.9, 32.5,
25.5; MS (ES) calcd for C21H16N2O3Na [M + Na]+ 367.1053, found 367.1055.

4-phenyl-1,9-dihydro-2H-indeno[2,1-b]pyridin-2-one (23).
To a solution of cycloadduct 28 (92.4 mg, 0.27 mmol) in PhMe (1.3 mL) was added
DBU (163 mg, 1.07 mmol). The reaction was heated to 200 °C for 1 h in the microwave
(300W, temperature mode). The reaction was cooled to rt, diluted with CH 2Cl2 (10
mL), transferred to a separatory funnel, and quenched with HCl (0.1 M, 12 mL). The
aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The combined organic layers
were neutralized with NaHCO3 (15 mL), washed with brine (15 mL), dried with
Na2SO4, filtered, and concentrated in vacuo. The compound 23 with 20% isomer (17
mg, 25% yield) was obtained following purification by flash column chromatography
on silica gel (elution: EtOAc, then 5% MeOH in CHCl3). A recrystallization (hot CHCl3
then hexanes) furnished pure compound as a yellow solid, for analytical purposes.
61

mp 254-255 °C; TLC (5% MeOH/CHCl3) Rf = 0.36 (UV, KMnO4); IR (film) cm-1 1645,
1390, 740, 706 cm−1; 1H NMR (400MHz, CDCl3): δ 12.6 (br s, 1H), 7.62 (d, J = 7.5
Hz, 1H), 7.47 (m, 6H), 7.38 (s, 1H), 7.35 (m, J = 7.5 Hz, 2H), 7.13 (t, J = 7.7 Hz, 1H),
7.01 (d, J = 7.7 Hz, 1H), 3.94 (s, 2H);

13C

NMR (100 MHz, CDCl3): δ 160.4, 148.7,

145.6, 140.3, 136.8, 134.2, 131.6, 130.1, 129.1, 129.0 128.4, 128.3, 126.7, 125.7,
123.5, 117.1, 79.6, 35.5; MS (ES) calcd for C18H13NONa [M + Na]+ 260.1070, found
260.1072.
Conventional heating (non-microwave, 110 °C) gave 16% isolated yield.

(3S*,9aS*)-11-acetyl-4-((benzyloxy)methyl)-3,9-dihydro-3,9a(epiminomethano)indeno[2,1-b]pyridine-2,10(1H)-dione

[Not

chiral

non

racemic] (27).
Produced according to general procedure B with 1 (176 mg, 0.89 mmol) and 14 (234
mg, 0.94 mmol). The pure compound 27 (226 mg, 0.582 mmol, 65% yield) was
obtained following purification by flash column chromatography on silica gel (elution:
10% to 60% EtOAc in hexanes) as a white amorphous solid. TLC (40%
EtOAc/hexanes) Rf = 0.2 (UV, CAM); IR (film) cm-1 3220, 2050, 2856, 2352, 1698,
1331, 1244, 740, 600 cm−1; 1H NMR (400MHz, CDCl3): δ 7.43 (d, J = 7.7 Hz, 1H),
7.34 (m, 7H), 7.23 (t, J = 2.5 Hz, 1H), 7.10 (br s, 1H), 6.13 (d, J = 1.84 Hz, 1H), 4.55
(s, 2H), 4.52 (s, 2H), 4.20 (d, J = 17.9 Hz, 1H), 3.28 (d, J = 17.9 Hz, 1H), 2.52 (s, 3H);
13C

NMR (100 MHz, CDCl3): δ 171.5, 169.2, 168.5, 150.1, 145.5, 137.2, 132.7, 131.1,
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130.7, 128.5, 128.0, 128.0, 126.1, 125.0, 72.7, 70.4, 65.6, 59.6, 32.6, 25.5; MS (ES)
calcd for C23H20N2O4Na [M + Na]+ 411.1315, found 411.1314.

4-((benzyloxy)methyl)-1,9-dihydro-2H-indeno[2,1-b]pyridin-2-one (22).
To a solution of cycloadduct 27 (52 mg, 0.13 mmol) in PhMe (1.3 mL) was added
DBU (61 mg, 0.40 mmol). The reaction was heated to 120 °C for 20 h. The reaction
was cooled to rt, diluted with CH2Cl2 (10 mL), transferred to a separatory funnel,
quenched with HCl (0.1 M, 10 mL), and extracted with CH2Cl2 (3 x 10 mL). The
combined organic layers were neutralized with NaHCO3 (10 mL), washed with brine
(10 mL), dried with Na2SO4, filtered, and concentrated in vacuo. The pure compound
22 (20 mg, 0.066 mmol, 49% yield) was obtained following purification by flash column
chromatography on silica gel (elution: 20% to 60% EtOAc in hexanes and 1% to 8%
MeOH in CHCl3) as a brown solid. mp 188-190 TLC (5% MeOH/CHCl3) Rf = 0.16 (UV,
KMnO4); IR (film) cm-1 2357, 1651, 1541, 1460, 748 cm−1; 1H NMR (400MHz, CDCl3):
δ 12.6 (br s, 1H), 7.96 (d, J = 7.5 Hz, 1H), 7.65 (d, J = 7.5 Hz, 1H), 7.47 (s, 1H), 7.43
(m, 2H), 7.36 (s, 2H), 7.35 (s, 2H), 7.32 (m, 1H), 4.76 (s, 2H), 4.64 (s, 2H), 3.90 (s,
2H);

13C

NMR (100 MHz, CDCl3): δ 163.0, 152.0, 145.3, 139.9, 137.6, 134.1, 131.4,

128.6, 128.5, 127.9, 127.8, 127.0, 125.1, 124.8, 113.5, 71.8, 67.7, 35.3; MS (ES)
calcd for C20H17NO2Na [M + Na]+ 326.1151, found 326.1151.
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2-chloro-9H-indeno[2,1-b]pyridine (SI-2).
Compound 10 (50 mg, 0.27 mmol) was dissolved in POCl3 (1 mL, 10.7 mmol) and
sealed in a vial with a Teflon cap. The reaction was heated at 100 °C for 16 h. The
reaction was cooled to rt, diluted with CH2Cl2 (5 mL), and transferred to a separatory
funnel with ice and NaOH (0.2 M, 54 mL). The aqueous layer was extracted with
CH2Cl2 (5 x 5 mL). The combined organic layers were washed with brine (20 mL),
dried with Na2SO4, filtered, and concentrated in vacuo. The extracted organic residue
afforded compound SI-2 (48 mg, 0.24 mmol, 87% yield) as a tan solid which did not
require further purification. mp 130-131 °C; TLC (5% MeOH/CHCl3) Rf = 0.25 (UV,
KMnO4); IR (film) cm-1 1601, 1552, 1409, 1170 cm−1; 1H NMR (400MHz, CDCl3): δ
8.40 (d, J = 5 Hz, 1H), 7.82 (d, J = 7.2 Hz, 1H), 7.62 (d, J = 6.6 Hz, 1H), 7.59 (d, J =
5 Hz, 1H), 7.46 (m, J1 = 6.6 Hz, J2 = 7.2 Hz, 2H), 3.93 (s, 2H);

13C

NMR (100 MHz,

CDCl3): δ 152.1, 148.4, 147.9, 143.5, 139.0, 136.6, 129.8, 127.4, 125.5, 121.8, 114.1,
36.2; MS (ES) calcd for C12H8ClNH [M + H]+ 202.0418, found 202.0417.

(3R*,9aS*)-11-acetyl-4-(trimethylsilyl)-3,9-dihydro-3,9a(epiminomethano)indeno[2,1-b]pyridine-2,10(1H)-dione
racemic] (29).
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[Not

chiral

non

Produced following general procedure B with 1 (695 mg, 3.51 mmol) and 16 (746 mg,
3.69 mmol). The pure compound 29 (602 mg, 1.93 mmol, 55% yield) was obtained
following purification by flash column chromatography on silica gel (elution: 15% to
65% EtOAc in hexanes) as an amorphous brown solid. Desilylated cycloadduct 9 (108
mg, 0.40 mmol, 12% yield) was formed over the course of the reaction and isolated
in its pure form from the same column. TLC (40% EtOAc/hexanes) Rf = 0.25 (UV,
CAM); IR (film) cm-1 3057, 2917, 2895, 1409, 731 cm−1; 1H NMR (400MHz, CDCl3):
δ 8.56 (s, 1H), 7.53 (d, J = 7.7 Hz, 1H), 7.39 (s, 1H), 7.38 (q, J = 7.7 Hz, 1H), 7.30 (m,
J = 7.7 Hz, 1H), 6.09 (s, 1H), 4.19 (d, J = 17.9 Hz, 1H), 3.20 (d, J = 17.9 Hz, 1H), 2.49
(s, 3H), 0.38 (s, 9H); 13C NMR (100 MHz, CDCl3): δ 171.6, 169.4, 168.3, 163.3, 146.3,
134.0, 133.5, 127.8, 126.3, 124.7, 71.3, 60.8, 32.6, 25.5, -0.9; MS (ES) calcd for
C18H20N2O3SiNa [M + Na]+ 363.1135, found 363.1137.

1,9-dihydro-2H-indeno[2,1-b]pyridin-2-one (10).
To a solution of 29 (36 mg, 0.12 mmol) in PhMe (1 mL) was added DBU (18 mg, 0.12
mmol). The reaction was heated to 110 °C for 14 h. The reaction was cooled to rt,
diluted with CH2Cl2 (10 mL), transferred to a separatory funnel, and quenched with
HCl (0.1 M, 10 mL). The aqueous layer was extracted with CH2Cl2 (3 x 10 mL). The
combined organic layers were neutralized with NaHCO3 (10 mL), washed with brine
(10 mL), dried with Na2SO4, filtered, and concentrated in vacuo. The crude residue
gave desilylated compound 10 and was not purified.
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1-(2-(diethoxymethyl)phenyl)but-2-yn-1-ol (45).
To a solution of 44 (5.4 g, 26 mmol) in THF (26 mL, 1M) at –78 °C was added 1propynylmagnesium bromide (5.5 g, 39 mmol) over 15 minutes via addition funnel.
After stirring for 25 min at –78 ˚C, the reaction was warmed to -40 °C and quenched
with diH2O (26 mL) and saturated NH4Cl (40 mL). The aqueous layer was extracted
with Et2O (2 x 20 mL) and diluted with hexanes (40 mL). The combined organic layers
were washed with brine, dried with Na2SO4, filtered, and concentrated in vacuo. The
pure compound 45 (5.15 g, 20.9 mmol, 80% yield) was obtained following purification
by flash column chromatography on silica gel (elution: 5% to 25% EtOAc in hexanes),
as an orange liquid. TLC: (20% EtOAc in hexane), Rf = 0.20; IR (film) cm-1 3415,
2970, 1051, 995, 750 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.77 (d, J = 6.9 Hz, 1H),
7.52 (d, J = 7.8 Hz, 1H), 7.38 (dd, J = 7.8 Hz, 6.9 Hz, 1H), 7.32 (dd, J = 7.8 Hz, 6.9
Hz, 1H), 5.89 (s, 1H), 5.80 (s, 1H), 3.90 (d, J = 5.3 Hz, 1H), 3.73-3.51 (m, 4H), 1.92
(s, 3H), 1.24 (t, J = 5.3 Hz, 6H);

13C

NMR (100 MHz, CDCl3): δ 139.3, 135.9, 129.1,

128.6, 127.9, 127.5, 101.5, 82.9, 78.5, 76.7 62.4, 62.3, 62.2, 15.0, 3.8; Exact mass
calcd for C15H20O3Na [M + Na]+ 271.1304, Found 271.1302.

tert-butyl((1-(2-(diethoxymethyl)phenyl)but-2-yn-1-yl)oxy)dimethylsilane (46).
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To a solution of 45 (940 mg, 3.8 mmol) in DMF (3.8 mL, 1M) was added imidazole
(620 mg, 9.1 mmol) and TBSCl (699 mg, 6.85 mmol). After 20h, the reaction was
diluted with diH2O (20 mL) and extracted with EtOAc (3 x 10 mL). The combined
organic layers were dried with Na2SO4, filtered, and concentrated in vacuo. The
extracted organic residue (1.3 g, 95% yield) afforded the pure compound 46 as a
yellow oil. TLC: (40% EtOAc in hexane), Rf = 0.44; IR (film) cm-1 2927, 1248, 1051,
835, 775, 752 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.68 (d, J = 8.0 Hz, 1H), 7.59 (d, J
= 8.0 Hz, 1H), 7.33 (t, J = 8.0 Hz, 1H), 7.27 (t, J = 8.0 Hz, 1H), 5.86 (s, 2H), 3.73-3.49
(m, 4H), 1.75 (s, 3H), 1.29-1.19 (m, 6H), 0.92 (s, 9H), 0.14 (s, 3H), 0.10 (s, 3H);

13C

NMR (100 MHz, CDCl3): δ 140.6, 134.9, 128.6, 127.1, 126.4, 126.1, 99.1, 81.2, 80.3,
62.0, 61.5, 61.0, 25.9, 18.3, 15.2, 3.8, -4.6, -4.9; Exact mass calcd for C21H34O3SiNa
[M + Na]+ 385.2169, Found 385.2168.

2-(1-((tert-butyldimethylsilyl)oxy)but-2-yn-1-yl)benzaldehyde (47).
To a solution of 46 (4.85 g, 13.4 mmol) in acetone (45 mL, 0.3M) at 0 °C was added
p-toluenesulfonic acid (1.27 g, 6.7 mmol). After 40 minutes, the reaction was
neutralized with saturated NaHCO3 (30 mL) and diluted with diH2O (20 mL). The
solution was extracted with EtOAc (3 x 30 mL). The combined organic layers were
washed with brine (30 mL), dried with Na2SO4, filtered, and concentrated in vacuo.
The extracted organic residue (3.68 g, 99% yield) afforded the pure compound 47 as
a yellow oil. TLC: (40% EtOAc in hexane), Rf = 0.93; IR (film) cm-1 2923, 1695, 1254,
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837, 781 cm−1; 1H NMR (400 MHz, CDCl3): δ 10.56 (s, 1H), 7.89 (d, J = 7.5 Hz, 1H),
7.65 (d, J = 7.5 Hz, 1H), 7.57 (t, J = 7.5 Hz, 1H), 7.43 (t, J = 7.5 Hz, 1H), 6.00 (s, 1H),
1.80 (s, 3H), 0.89 (s, 9H), 0.16 (s, 3H), 0.09 (s, 3H);

13C

NMR (100 MHz, CDCl3): δ

192.6, 144.6, 133.8, 133.0, 130.6, 128.0, 127.0, 83.1, 62.9, 25.7, 18.2, 3.7, -4.6, -5.0;
Exact mass calcd for C17H24O2SiNa [M + Na]+ 311.1438, Found 311.1438.

(Z)-1-acetyl-3-(2-(1-((tert-butyldimethylsilyl)oxy)but-2-yn-1yl)benzylidene)piperazine-2,5-dione (48).
To a solution of 1 (2.6 g, 13.3 mmol) in DMF (26 mL, 0.5 M) was added aldehyde 47
(3.68 g, 13.3 mmol) and cesium carbonate (4.6 g, 14 mmol). The reaction was stirred
until consumption of the aldehyde (1.5 h). The reaction was diluted with diH2O (50mL)
and extracted with EtOAc (4 x 20 mL). The combined organic layers were dried with
Na2SO4, filtered, and concentrated in vacuo. The pure compound 48 (2.77 g, 49%
yield) was obtained following purification by flash column chromatography on silica
gel (elution: 5% to 45% EtOAc in hexanes) as a white solid. mp 136-138 °C; TLC:
(20% EtOAc in hexane), Rf = 0.27; IR (film) cm-1 3242, 2929, 2855, 1709, 1696, 1681,
1366, 1231, 1220, 1036, 835 cm−1; 1H NMR (400 MHz, CDCl3): δ 7.68 (m, 2H), 7.45
(s, 1H), 7.42 (t, J = 7.4 Hz, 1H), 7.36 (t, J = 7.4 Hz, 1H), 7.21 (d, J = 7.4 Hz, 1H), 5.41
(s, 1H), 4.49 (s, 2H) 2.68 (s, 3H), 1.82 (s, 3H) 0.88 (s, 9H), 0.15 (s, 3H), 0.10 (s, 3H);
13C

NMR (100 MHz, CDCl3): δ 172.6, 162.4, 159.5, 141.9, 129.8, 129.5, 128.5, 127.9,
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127.6, 126.6, 119.1, 83.0, 79.2, 63.3, 46.2, 27.3, 25.7, 18.2, 3.7, -4.4, -5.0; Exact
mass calcd for C23H30N2O4SiNa [M + Na]+ 449.1867, Found 449.1867.

(3S*,10aS*)-12-acetyl-5-((tert-butyldimethylsilyl)oxy)-4-methyl-5,10-dihydro-1H3,10a-(epiminomethano)benzo[g]quinoline-2,11(3H)-dione

[Not

chiral

non

racemic] (49).
To a solution of 48 (426 mg, 1 mmol) in PhMe (26 mL, 0.5 M) was added NEt 3 (606
mg, 6 mmol) and TMSCl (435 mg, 4 mmol). The reaction was heated to 130 °C in a
sealed tube. After 21 h, the reaction was diluted with diH 2O (10 mL) and extracted
with EtOAc (3 x 20 mL). The combined organic layers were dried with Na 2SO4, filtered,
and concentrated in vacuo. The pure compound 49 (281 mg, 66% yield) was obtained
following purification by flash column chromatography on silica gel (elution: 15% to
45% EtOAc in hexanes), as a white amorphous solid. TLC: (20% EtOAc in hexane),
Rf = 0.271; IR (film) cm-1 2927, 1705, 1333, 1250, 1032, 835, 745 cm−1; 1H NMR (400
MHz, CDCl3): δ 7.40 (d, J = 7.3 Hz, 1H), 7.33 (t, J = 7.3 Hz, 1H), 7.24 (t, J = 6.6 Hz,
1H), 7.19 (s, 1H), 7.07 (s, 1H), 5.67 (s, 1H), 5.33 (s, 1H), 3.50 (m, 2H), 2.38 (s, 3H),
2.12 (s, 3H), 0.77 (s, 9H), 0.07 (s, 3H), -0.11 (s, 3H);

13C

NMR (100 MHz, CDCl3): δ

170.8, 169.2, 168.6, 141.5, 136.8, 129.5, 129.1, 127.3, 77.2, 64.1, 60.6, 30.1, 25.5,
25.1, 18.0, 15.8, -4.7; Exact mass calcd for C23H30N2O4SiNa [M + Na]+ 449.1867,
Found 449.1865.
1Indistinguishable

from starting material by TLC
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4-methylbenzo[g]quinolin-2(1H)-one (50).
To a solution of cycloadduct 49 (33 mg, 0.08 mmol) in PhMe (0.1 M) was added DBU
(59 mg, 0.387 mmol). The reaction was heated to 200 °C for 1 h in the microwave
(300W, temperature mode). The reaction was cooled to rt, diluted with EtOAc (3 mL),
transferred to a separatory funnel, and quenched with HCl (0.1 M, 5 mL). The aqueous
layer was extracted with EtOAc (5 x 5 mL). The combined organic layers were
neutralized with NaHCO3 (5 mL), washed with brine (5 mL), dried with Na2SO4,
filtered, and concentrated in vacuo. Compound 50 (10 mg, 62% yield) was obtained
following purification by flash column chromatography on silica gel (elution: 2% to 7%
MeOH and CHCl3), as a white solid. mp 172-174 °C; TLC product: (5% MeOH/CHCl3)
Rf = 0.43 (UV, KMnO4); IR (film) cm-1 3041, 2891, 1672, 1645, 1622, 1500, 1362,
1182, 875, 739 cm−1; 1H NMR (400 MHz, CDCl3): δ 9.76 (br s, 1H), 9.01 (s, 1H), 8.08
(d, J = 9.4 Hz, 2H), 8.00 (d, J = 9.4 Hz, 1H), 7.62 (t, J = 7.2 Hz, 1H), 7.55 (t, J = 7.2
Hz, 1H), 6.91 (d, J = 4.8 Hz, 1H), 2.40 (s, 3H); 1H NMR (400 MHz, DMSO-d6): δ 10.9
(br s, 1H), 8.90 (m, 2H), 8.11 (d, J = 8.4 Hz, 1H), 7.66 (t, J = 7.5 Hz, 1H), 7.57 (t, J =
7.8 Hz, 1H), 6.91 (d, J = 4.6 Hz, 1H), 2.32 (s, 3H);

13C

NMR (100 MHz, CDCl3): δ

164.0, 135.4, 134.3, 131.5, 129.4, 129.2, 128.3, 127.9, 126.1, 124.4, 123.7, 122.0,
112.4, 15.7;

13C

NMR (100 MHz, DMSO-d6): δ 140.0, 139.5, 136.0, 134.4, 133.3,
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133.0, 131.2, 130.5, 129.9, 126.9, 126.8, 115.2, 20.2; MS (ES) calcd for C14H11NONa
[M + Na]+ 232.0733, found 232.0732.
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Chapter 3
The Synthesis and Fluorescence of Azafluorenones
The Fluorophores Fluorene and Fluorenone
Fluorene is a tricyclic 6,5,6 ring system consisting of two benzenes ring-fused
to cyclopentadiene. It is a commercial byproduct of coal tar.1 The hydrogens at the 9
position (the saturated position) are relatively acidic owing to the aromaticity of the
deprotonated cyclopentadienyl moiety. This property allows fluorene to act as a ligand
for transition metals. Fluorene is the precursor to the fluorenylmethyloxycarbonyl
(Fmoc) protecting group used in amide coupling (Figure 3.1).

Figure 3.1 Fluorene and derived compounds
Fluorene fluoresces violet, which has inspired continuous interest in the
molecule as a blue light source. Polyfluorene materials are used in polymer lightemitting diodes (PLEDs) due to emitting deep blue. During PLED operation a second
green emission band appears which is attributed to oxidative degradation of fluorene
units.2-3 This green emission is strengthened by increased intermolecular interactions
and can be attributed solely to oxidation on the polymeric chain, 4-5 or also to formation
of inter-chain aggregates and excimers.6-7 This point is fiercely debated in the
literature, but there is more evidence for the former. Oxidative defects are enhanced
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by calcium ions present in cathodes; this can be avoided by including a buffer layer
between the cathode and the polyfluorene.8 Additionally, polyfluorenes have been
used as fluorescent chemosensors for explosives detection.9
Fluorenone, the oxidized version of fluorene, can be considered a
conformationally rigid analogue of benzophenone and is a planar system with the
lowest triplet state being π−π*10 (Figure 3.2). Fluorenone fluoresces yellow but
fluorenone based polymers typically fluoresce green and can be photoactivatable. 11
Fluorenone has been used as a photosensitizer which catalyzes benzylic C-H
fluorination.12 The interconversion between fluorenone and its reduced counterpart
fluorenol has been shown to reversibly store hydrogen through a catalytic and
electrolytic process.13 Interestingly, fluorenol itself is a promising wakefulness
promoting (eugeroic) drug which is significantly more potent than the widely used
modafinil (brand name Provigil).14 Fluorenone derivatives have been used as probes
for DNA redox chemistry15 and intramolecular charge-transfer (ICT) compounds for
use in nonlinear optics.16 Substituted fluorenone organic crystals can exhibit two color
luminescence switching in the solid state via stimulation with temperature, pressure,
or solvent vapor.17 This switching is caused by intermolecular π−π stacking with
directed packing by hydrogen bonding.

Figure 3.2 Fluorenone and related compounds
Fluorenone has atypical spectroscopic properties which has generated
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continual interest in its photochemistry. It is a popular model for studying excited state
hydrogen bonding behaviors due to measurable changes in its fluorescence in protic
solvents. Hydrogen bonding is significantly strengthened in fluorenone’s excited state,
decreasing the energy gap between the fluorescent ground and excited states. 18 At
the same time, hydrogen bonding quenches fluorescence by promoting radiationless
deactivation via internal conversion (IC),18-19 rather than the intersystem crossing
(ISC) which dominates in aprotic solvents.
Synthesis and Fluorescence of Azafluorenones
We prepared several 6,5,6 tricyclic 2-pyridones through the synthetic
methodology detailed in the second chapter. These molecules are considered
azafluorenes, as they have the fluorene core structure featuring the pyridone motif.
Additionally, a fluoro-substituted azafluorene, 2, was synthesized by Tristan Elmore
with eventual goal of amine substitution to alter downstream fluorescence activity
(Figure 3.3). These azafluorenes were tested for fluorescence via excitation at the
ranges which they absorbed light (330-365 nm excitation). No fluorescence was
observed.

Figure 3.3 Azafluorenes synthesized for fluorescent studies
Next, we oxidized the azafluorenes to azafluorenones to probe their
fluorescent activity. This was accomplished easily and cleanly via cesium carbonate
in dimethyl formamide (Scheme 3.1). The reaction was open to air but was fitted with
a Drierite dessicant tube to avoid ambient moisture.
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Scheme 3.1 Synthesis of Azafluorenones from Azafluorenes
Both the simple azafluorenone 3 and the fluorine containing azafluorenone 4
showed fluorescent activity when excited at 365 nm. The compounds were
fluorescent in both aprotic tetrahydrofuran and the protic solvent ethanol, but exhibited
minor quenching in ethanol presumably due to hydrogen bonding. Compound 3
showed one main fluorescent peak at 529 nm, which was broadened from 450 nm to
650 nm. Compound 4 showed two fluorescent peaks at 410 nm and 491 nm, with the
latter broadening from 450 nm to 600 nm and having higher intensity. The peak at
410 nm disappeared when 4 was dissolved in ethanol.
We then became curious as to whether the pyridone motif played a significant
role in the fluorescence of the azafluorenones. To this end, we converted the
pyridones to chloropyridines with refluxing phosphoryl chloride (Scheme 3.2). The
fluorescence of chloropyridine azafluorenones 5 and 6 was highly quenched when
excited at 365 nm. 5 appeared not fluorescent at all, whereas the only fluorescent
peak of 6 was the previously minor peak at 410 nm.
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Scheme 3.2 Synthesis of Chloropyridine Azafluorenones
We next oxidized a phenyl substituted 6,5,6 pyridine (synthesized by Robert
Wiley of our lab) to the azafluorenone under the same conditions as 1 and 2 (Scheme
3.3). 2-Alkylated azafluorenones have been synthesized previously in the literature
(typically en route to larger molecules), but were not examined for their fluorescence
activity. Phenyl azafluorenone 7 absorbed significantly more light than the
chloropyridines 5 and 6, appearing strikingly yellow in visible light. However, 7 showed
no fluorescence when excited at 330 nm and 365 nm, despite absorbing strongly in
these regions.

Scheme 3.3 Synthesis of a 2-Phenyl Azafluorenone
Finally, we oxidized a 2-methoxy 6,5,6 pyridine, which had been previously
synthesized by our lab, into a 2-methoxy azafluorenone (Scheme 3.4). This molecule
absorbed at a lower frequency than previous compounds and showed weak
fluorescence in the yellow region (570 nm) when excited at 270 nm in THF. Ethanol
quenched the fluorescence.
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Scheme 3.4 Synthesis of a 2-Methoxy Azafluorenone
Conclusion
Azafluorenes and azafluorenones were synthesized in concise fashion and
tested for their fluorescence. The presence of oxygen at the 2-position appears
responsible for the fluorescence of our azafluorenones, which is especially strong in
the compounds containing a pyridone. This is exciting because the pyridone moiety
is not widely explored in regard to its emissive properties. This discovery paves the
way for fluorescent azafluorenone polymers, as the fluorescent emissions observed
in the violet (410 nm), blue (491 nm), and green (529 nm) spectral domains are
industrially valuable.
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Experimental
General procedure A: Synthesis of azafluorenones
To a solution of azafluorene (1 equiv, 0.1-1.6 mmol) in DMF (0.2 M) was added
Cs2CO3 (3 equiv). The vessel was capped with a Drierite-filled tube and allowed to
stir open to atmosphere for 16 h. The reaction was diluted with di-H2O (10 mL) and
extracted with CH2Cl2 (3 x 10 mL). The combined organic layers were washed with
brine (10 mL), dried with Na2SO4, filtered, and concentrated in vacuo.

General procedure B: Synthesis of chloropyridine azafluorenones
Azafluorenone (1 equiv, 0.1-0.2 mmol) was dissolved in POCl3 (0.3 M), sealed in a
vial with a Teflon cap, and heated to 100 °C for 16 h. The reaction was diluted with
CH2Cl2 (10 mL), transferred to a separatory funnel with ice and NaOH (3.1 equiv to
POCl3), and extracted with additional CH2Cl2 (3 x 10 mL). The combined organic
layers were washed with brine (10 mL), dried with Na2SO4, filtered, and concentrated
in vacuo.

1H-indeno[2,1-b]pyridine-2,9-dione (3).
Produced according to general procedure A with 1 (300 mg, 1.64 mmol). The organic
residue afforded compound 3 (130 mg, 0.64 mmol, 40% yield) as a black solid which
did not require further purification. mp 274-275 °C; TLC (5% MeOH/CHCl3) Rf = 0.26
(UV, CAM); IR: 1719, 1620, 1586, 1548, 1175, 1023, 994, 749, 689 cm−1; 1H NMR
(400MHz, DMSO-d6): δ 12.3 (br s, 1H), 7.96 (d, J = 6.3 Hz, 1H), 7.86 (d, J = 7.2 Hz,
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1H), 7.63 (t, J = 7.2 Hz, 1H), 7.55 (m, 2H), 6.90 (d, J = 6.3 Hz, 1H);

13C

NMR (100

MHz, DMSO-d6): δ 190.6, 162.0, 157.5, 146.8, 139.5, 134.3, 133.9, 132.3, 123.2,
123.1, 116.3, 99.9; MS (ES) calcd for C12H7NO2Na [M + Na]+ 220.0369, found
220.0369.

6-fluoro-1H-indeno[2,1-b]pyridine-2,9-dione (4).
Produced according to general procedure A with 2 (26 mg, 0.13 mmol). The organic
residue afforded compound 4 (12.3 mg, 0.06 mmol, 43% yield) as a dark yellow solid
which did not require further purification. mp 324-326 °C; TLC (10% MeOH/CHCl3) Rf
= 0.38 (UV, KMnO4); IR: 3090, 1707, 1641, 1587, 1471, 1190, 795 cm −1; 1H NMR
(400MHz, DMSO-d6): δ 12.34 (s, 1H), 7.99 (d, J = 6.3 Hz, 1H), 7.84 (dd, J1 = 8.4 Hz,
J2 = 2.2 Hz, 1H), 7.61 (dd, J1 = 8.4 Hz, J2 = 5.4 Hz, 1H), 7.32 (m, 1H), 6.93 (d, J = 6.3
Hz, 1H); 13C NMR (100 MHz, DMSO-d6): δ 188.5, 165.7, 159.8, 156.8, 146.5, 142.2,
129.6, 124.9, 117.8, 116.5, 110.9, 99.6; MS (ES) calcd for C12H6FNO2Na [M + Na]+
238.0274, found 238.0273.

2-chloro-9H-indeno[2,1-b]pyridin-9-one (5).
Produced according to general procedure B with 3 (54.5 mg, 0.23 mmol). The
extracted organic residue afforded compound 5 (39 mg, 0.18 mmol, 79% yield) as a
tan solid which did not require further purification. mp 188-190 °C; TLC (5%
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MeOH/CHCl3) Rf = 0.64 (UV, CAM); IR: 1709, 1587, 1556, 1431, 1412, 1177, 1150,
914, 738 cm−1; 1H NMR (400MHz, CDCl3): δ 8.53 (d, J = 4.9 Hz, 1H), 7.76 (d, J = 7.4
Hz, 1H), 7.63 (m, 2H), 7.51 (t, J = 7.4 Hz, 1H), 7.46 (d, J = 4.9 Hz, 1H);

13C

NMR

(100 MHz, CDCl3): δ 189.5, 155.5, 155.4, 147.9, 140.1, 135.1, 133.6, 132.1, 124.9,
124.8, 121.9, 114.6; MS (ES) submitted for C12H6ClNOH [M + H]+

2-chloro-6-fluoro-9H-indeno[2,1-b]pyridin-9-one (6).
Produced according to general procedure B with 4 (30 mg, 0.14 mmol). Purification
by flash column chromatography (elution: 20-60% EtOAc in hexanes) afforded pure
compound 6 (13 mg, 0.06 mmol, 41% yield) as a tan solid. mp 237-240 °C; TLC (10%
MeOH/CHCl3) Rf = 0.74 (UV, KMnO4); IR: 3086, 1711, 1593, 1562, 1352, 1198, 860,
791 cm−1; 1H NMR (400MHz, CDCl3): δ 8.58 (d, J1 = 5.1 Hz, J2 = 1.8 Hz, 1H), 7.80
(ddd, J1 = 8.4, J2 = 5.1, J3 = 1.8 Hz, 1H), 7.45 (dd, J1 = 5.1 Hz, J2 = 1.8 Hz, 1H), 7.35
(dt, J1 = 7.8 Hz, J2 = 2.0 Hz 1H), 7.19 (tt, J1 = 8.4 Hz, J2 = 2.0 Hz, 1H); 13C NMR (100
MHz, CDCl3): δ 187.9, 167.3, 155.8, 153.9, 148.1, 143.1, 129.8, 127.3, 125.3, 119.0,
114.8, 110.1 MS (ES) submitted for C12H5ClFNOH [M + H]+

2-methoxy-9H-indeno[2,1-b]pyridin-9-one (8).
Produced according to general procedure A with SI-2 (21.8 mg, 0.11 mmol). The
extracted organic residue afforded compound 8 (12.2 mg, 0.06 mmol, 56% yield) as
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a yellow solid which did not require further purification. mp 136-138 °C; TLC (50%
CHCl3/hexanes) Rf = 0.30 (Visible light, UV, CAM); IR: 1726, 1306, 1258, 843 cm−1;
1H

NMR (400MHz, CDCl3): δ 7.72 (d, J = 8.0 Hz, 1H), 7.62 (d, J = 7.1 Hz, 1H), 7.45

(t, J = 7.5 Hz, 1H), 7.34 (d, J = 7.1 Hz, 1H), 7.24 (t, J = 7.5 Hz, 1H), 6.81 (d, J = 8.0
Hz, 1H), 4.04 (s, 3H);

13C

NMR (100 MHz, CDCl3): δ 192.9, 165.9, 150.6, 142.0,

135.2, 134.8, 131.9, 130.5, 128.6, 124.6, 119.7, 115.5, 54.3; MS (ES) submitted for
C13H9NO2Na [M + Na]+

2-phenyl-9H-indeno[2,1-b]pyridin-9-one (7).
Produced according to general procedure A with SI-1 (28 mg, 0.11 mmol). The
extracted organic residue afforded compound 7 (25 mg, 0.10 mmol, 87% yield) as a
yellow solid which did not require further purification. mp 177-179 °C; TLC (20%
EtOAc/hexanes) Rf = 0.30 (Visible light, UV, CAM); IR: 1727, 1603, 1450, 1302 cm−1;
1H

NMR (400MHz, CDCl3): δ 8.05 (d, J = 7.2 Hz, 2H), 7.86 (d, J = 8 Hz 1H), 7.74 (d,

J = 8 Hz, 1H), 7.71 (d, J = 7.2 Hz, 1H), 7.49 (m, 5H), 7.33 (t, J = 6.8 Hz, 1H); 13C NMR
(100 MHz, CDCl3): δ 192.8, 158.4, 153.3, 141.7, 138.4, 138.1, 135.5, 132.6, 129.8,
129.5, 128.8, 127.0, 124.8, 123.8, 121.0; MS (ES) submitted for C18H11NONa [M +
Na]+
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